MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze LFMD →
    • FindStock Picks / Stock Screener
    • Value · LFMDIntrinsic Value Calculator
    • Invest · LFMDInvestment Case
    • Hold · LFMD5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
LFMD stock logo

LFMD

LifeMD, Inc.

$2.2
0.54
 (32.63%)
Exchange:  NASDAQ
Market Cap:  105.922M
Shares Outstanding:  45.13M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  Medical – Healthcare Information ServicesView industry performance
   
CEO:  Justin Schreiber
Full Time Employees:  350
Address: 
236 Fifth Avenue
New York City
NY
10001
US
Website:  https://www.lifemd.com
LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men’s sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men’s telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.

Click to read more…

Revenue Segmentation

Revenue by type

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Log in — it's free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
LFLFMD logoLFMDLifeMD, Inc.105.9M——-410.1%
CCCCLD logoCCLDCareCloud, Inc.103.0M18.615.118.4%
HCHCAT logoHCATHealth Catalyst, Inc.115.0M——-34.2%
OPOPRX logoOPRXOptimizeRx Corp.138.3M27.89.04.7%
DHDH logoDHDefinitive Healthcare Corp.140.4M—6.641.9%
HCHCTI logoHCTIHealthcare Triangle, Inc.3.7M——-32.7%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Log in — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/05/06 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Log in — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue152,547.006212,453.838194,055.198
Gross Profit133,646.542188,385.359154,760.754
EBITDA-8,214.245-6,652.976-1,517.087
Operating Income-14,489.273-16,144.681-7,669.694
Net Income-20,595.992-18,881.732-7,106.359

Log in to continue

Log in to see the income statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets58,480.70972,460.02670,411.319
Total Liabilities52,914.55076,505.39447,254.739
Total Stockholders Equity3,505.372-5,485.50123,156.580
Total Debt18,932.35325,103.2306,323.796
Cash and Cash Equivalents33,146.72535,004.92436,786.318

Log in to continue

Log in to see the balance sheet and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow8,820.23217,513.1908,280.175
Capital Expenditure-8,733.284-11,536.318-1,870.665
Free Cash Flow86.9485,976.8726,409.510
Net Income-20,595.992-18,728.49815,619.791
Net Change in Cash29,187.7681,858.1991,781.394

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)263,680.936Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)291,355.326Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)273,622.333Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)12,400.356Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)25,570.831Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)18,962.891Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)-688.820Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)11,709.781Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)5,510.481Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)251,888.078Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)278,324.759Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)261,384.856Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)0.120Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)0.260Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)-0.020Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)5Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)5Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access to see up to 5 years of analyst estimates.

Create a free account

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
212.454M  ?P/S
 (TTM)
: 
0.56
?Net Income
 (TTM)
: 
-18.882M  ?P/E
 (TTM)
: 
-4.23
?Enterprise Value
 (TTM)
: 
90.023M  ?EV/FCF
 (TTM)
: 
-5.61
?Dividend Yield
 (TTM)
: 
0%  ?Payout Ratio
 (TTM)
: 
-14.17%
?ROE
 (TTM)
: 
-192.39%  ?ROIC
 (TTM)
: 
-410.15%
?Net Debt
 (TTM)
: 
-9.902M  ?Debt/Equity
 (TTM)
: 
-10.1
?P/B
 (TTM)
: 
-182.45  ?Current Ratio
 (TTM)
: 
0.8

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Log in — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
N/AResearch AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access for forward P/E high/low estimates and the full multi-year table.

Create a free account

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates LFMD intrinsic value between $1.87 – $1.95 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate LFMD Intrinsic Value

Common questions about LFMD valuation

Is LifeMD, Inc. (LFMD) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for LifeMD, Inc. (LFMD) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is LFMD a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether LFMD trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is LFMD’s P/E ratio?

You can see LFMD’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for LFMD?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is LFMD a good long-term investment?

Whether LFMD fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for LifeMD, Inc.

  • LifeMD, Inc. intrinsic value calculatorEstimate what the business is worth
  • LifeMD, Inc. 5-year outlookWhat has to go right, and what could go wrong
LFMD

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

32.63
MarketSnap

Trading Metrics:

Open: 1.87   Previous Close: 1.66
Day Low: 1.85   Day High: 2.34
Year Low: 1.6   Year High: 5.38
Price Avg 50: 2.62   Price Avg 200: 3.6
Volume: 6.141M   Average Volume: 915800

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Log in — it's free
See in Nexus

Relevant news

LifeMD, Inc. (LFMD) Q3 2026 Earnings Call Transcript
13-11-2026 04:38
LifeMD, Inc. (LFMD) Q3 2026 Earnings Call Transcript
What LifeMD (LFMD) Said on Its Q3 Earnings Call
12-11-2026 18:15
What LifeMD (LFMD) Said on Its Q3 Earnings Call
LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026
06-11-2026 19:25
LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
22-09-2026 17:01
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
LifeMD: Still Undervalued Despite Earnings Miss
16-09-2026 09:29
LifeMD: Still Undervalued Despite Earnings Miss
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates
05-08-2026 21:37
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

How MarketSnap works

What’s new

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze LFMD →
    • FindStock Picks / Stock Screener
    • Value · LFMDIntrinsic Value Calculator
    • Invest · LFMDInvestment Case
    • Hold · LFMD5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Settings
    • Public profile ↗
  • Log in

Media

Watch Listen Read
Ask MarketSnap AI

MarketSnap AI Assistant

Uses MarketSnap data and this page

Ready

🔒 You are currently logged out

Login

It's free

MarketSnap Assistant · Tips
    MarketSnap

    Welcome to MarketSnap

    The AI-powered workspace for stock pickers.

    Continue with Google Continue with email

    Already a member? Sign in

    Find stocks·Value them·Build the case·Journal decisions·Track what changes

    Free to join. No card needed. Privacy Policy

    Create your free MarketSnap account Continue with Google
    Chat with us MarketSnap support · account, plans, settings, help
    How MarketSnap works

    The conversation above goes to the MarketSnap team with your message. We reply by e-mail.